vers la météo de la validation par utilisateur
+------------------------------COMP:V_PASS-N(in)-----------------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:V_PASS-N(in) (associate,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-------------COMP:V-N(in)-------------+ +---------------------SUBJ:V-N--------------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+COMP:N-N(of)+ +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------------SUBJ:V-N--------------------+-------------COMP:V-N(in)-------------+ +---------------COMP:N-N(of)--------------+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+ | +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------COMP:N-N(of)-------+----------COMP:N-N(in)---------+ | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------COMP:N-N(of)-------+----------COMP:N-N(in)---------+ | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+------------------------COMP:N-N(in)-----------------------+ +--------COMP:N-N(of)-------+ | | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,line) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------COMP:N-N(of)-------+ | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+----------COMP:N-N(in)---------+ +---------------------SUBJ:V-N--------------------+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+COMP:N-N(of)+ +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+------------------------COMP:N-N(in)-----------------------+ +--------COMP:N-N(of)-------+ | | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,line) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------COMP:N-N(of)-------+ | +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------------SUBJ:V-N--------------------+-------------COMP:V-N(in)-------------+ +-------COMP:N-N(with)-------+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+ +COMP:N-N(of)+ +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) SUBJ:V_PASS-N (associate,human) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------------SUBJ:V-N--------------------+ +----------COMP:N-N(in)---------+ +---------------COMP:N-N(of)--------------+ | | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+ | +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------COMP:N-N(of)-------+ +--------SUBJ:V-N-------+ +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ | +--MOD_ATT:N-ADJ-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V-N (be,upregulation) MOD_ATT:N-ADJ (upregulation,associate) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------------SUBJ:V-N--------------------+ +---------------COMP:N-N(of)--------------+ +-------------COMP:V-N(in)-------------+ +-------COMP:N-N(with)-------+ | | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+ | | +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------COMP:N-N(of)-------+----------COMP:N-N(in)---------+ +--------SUBJ:V-N-------+ +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ | +--MOD_ATT:N-ADJ-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V-N (be,upregulation) MOD_ATT:N-ADJ (upregulation,associate) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+------------------------------COMP:V_PASS-N(in)-----------------------------+ | +---------------OBJ:V-N--------------+ +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:V_PASS-N(in) (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------------SUBJ:V-N--------------------+ +----------COMP:N-N(in)---------+ +-------COMP:N-N(with)-------+ | | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+ +COMP:N-N(of)+ +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) SUBJ:V_PASS-N (associate,human) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+------------------------COMP:N-N(in)-----------------------+ +--------COMP:N-N(of)-------+ | +--------SUBJ:V-N-------+ +-MOD_ATT:N-ADJ+ +---MOD_ATT:N-N--+ | +--MOD_ATT:N-ADJ-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V-N (be,upregulation) MOD_ATT:N-ADJ (upregulation,associate) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,line) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+------------------------------COMP:V_PASS-N(in)-----------------------------+ | +---------------OBJ:V-N--------------+ | | | +----COMP:N-N(of)----+ | +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:V_PASS-N(in) (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ | +---------------OBJ:V-N--------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ +-------------------OBJ:V-N------------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,line) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ | +---------------OBJ:V-N--------------+ | | | +----COMP:N-N(of)----+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ +-------------------OBJ:V-N------------------+ | | +----COMP:N-N(of)----+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,line) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------------SUBJ:V-N--------------------+ +---------------COMP:N-N(of)--------------+ | +----------COMP:N-N(in)---------+ +-------COMP:N-N(with)-------+ | | | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+SUBJ:V_PASS+ | | +OBJ:V-+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ +------------------------COMP:V-N(in)-----------------------+ | | +--------COMP:N-N(of)-------+ | | | | +-MOD_ATT:N-ADJ+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,cholangiocarcinoma) OBJ:V-N (associate,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cell)
+----------COMP:N-N(in)---------+ +---------------OBJ:V-N--------------+ +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------OBJ:V-N--------------+----------COMP:N-N(in)---------+ | +----COMP:N-N(of)----+ | +---MOD_ATT:N-N--+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+----------COMP:N-N(in)---------+ +---------------OBJ:V-N--------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+----------COMP:N-N(in)---------+ +-------------------OBJ:V-N------------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+---------------OBJ:V-N--------------+----------COMP:N-N(in)---------+ | +----COMP:N-N(of)----+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-------------------------------OBJ:V-N------------------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+-COMP:N-N(in)-+ +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) OBJ:V-N (with,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-------------------OBJ:V-N------------------+----------COMP:N-N(in)---------+ | +----COMP:N-N(of)----+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-------------------------------OBJ:V-N------------------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+-COMP:N-N(in)-+ +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (with,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+-COMP:N-N(in)-+ +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-------------------------------OBJ:V-N------------------------------+ | +---------------COMP:N-N(in)---------------+ | | +--------COMP:N-N(of)-------+ | | | | +-MOD_ATT:N-ADJ+ | | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) OBJ:V-N (with,line) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,cholangiocarcinoma) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cell)
+-------------------------------OBJ:V-N------------------------------+ | +---------------COMP:N-N(in)---------------+ | | +--------COMP:N-N(of)-------+ | | | | +-MOD_ATT:N-ADJ+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (with,line) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,cholangiocarcinoma) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ | +---------------COMP:N-N(in)---------------+ | | +--------COMP:N-N(of)-------+ | | | | +-MOD_ATT:N-ADJ+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | +MOD_+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,line) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,cholangiocarcinoma) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ +-------------------OBJ:V-N------------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,line) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,line) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cell)
+----------COMP:N-N(in)---------+ +-------------------OBJ:V-N------------------+ +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | | +MOD_+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:N-N(of) (upregulation,__SP__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+--------------------------------COMP:V-N(in)--------------------------------+ +-------------------OBJ:V-N------------------+ | | +-----------OBJ:V-N-----------+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | | | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,line) OBJ:V-N (with,__NODE__) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ +------------------------COMP:V-N(in)-----------------------+ | | +---------------OBJ:V-N--------------+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,cholangiocarcinoma) OBJ:V-N (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ +------------------------COMP:V-N(in)-----------------------+ | | +---------------OBJ:V-N--------------+ | | | | +----COMP:N-N(of)----+ | | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,cholangiocarcinoma) OBJ:V-N (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) MOD_ATT:N-N (line,cell)
+-------------------OBJ:V-N------------------+----------COMP:N-N(in)---------+ | +-----------OBJ:V-N-----------+ | +---MOD_ATT:N-N--+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | | | +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) OBJ:V-N (with,__NODE__) COMP:N-N(of) (upregulation,__SP__) COMP:N-N(in) (mRNA,line) MOD_ATT:N-N (line,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ | +---------------OBJ:V-N--------------+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+-COMP:N-N(in)-+ +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma) MOD_ATT:N-N (line,cell)
+-----------------------------------OBJ:V-N----------------------------------+ | +---------------OBJ:V-N--------------+ | | | +----COMP:N-N(of)----+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ +-COMP:N-N(in)-+ +MOD_+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma cell lines . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,line) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,cholangiocarcinoma) MOD_ATT:N-N (line,cell)